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Abstract 
Cysteine-containing antimicrobial peptides of diverse phylogeny share a common structural 
signature, the  core, characterized by a strong polarization of charges in two antiparallel  sheets. 
In this work we analyzed peptides derived from the tomato defensin SolyC07g007760 
corresponding to the protein  core and demonstrated that cyclization of the peptides, which 
results in segregation of positive charges to the turn region, produces peptides very active against 
Gram negative bacteria, such as Salmonella enterica and Helicobacter pylori. Interestingly these 
peptides show very low hemolytic activity and thus represent a scaffold for the design of new 
antimicrobial peptides. 
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Introduction 
A tremendous effort has been recently devoted to the discovery of biologically active peptides 
from natural sources.[1-3] Plants produce a wide variety of antimicrobial peptides and proteins 
showing activity against either plant or human pathogens.[4] Many of these, such as thionins and 
knottins are rich in cysteines and are stabilized by a number of disulfide bonds.[5, 6] Interestingly 
some of the structural features displayed by peptides produced in plants are well conserved also 
within proteins produced by evolutionarily diverse organisms and, in fact, the existence of 
multidimensional signatures for antimicrobial peptides has been hypothesized.[7-9] Thecore 
motif has recently been indicated as a three dimensional signature for antimicrobial peptides or 
proteins and, generally, as a feature shown by membrane-active proteins. In particular, the  core 
motif, characterized by a conserved CXG sequence and two antiparallel  sheets, is common to 
host defence polypeptides showing multiple disulfide bonds such as toxins, kinocidins and 
thionins.[10, 11] This structural motif can be generated by different amino acid sequences and can 
exist in the dextromeric or levomeric form, depending on whether it is derived by the amino acid 
forward or reverse sequence (Figure 1). In all cases  core motifs show polarization of positive 
charge and segregation of hydrophobic amino acids. There are some cases in which the only  core 
is sufficient for the peptide antimicrobial activity, as observed for protegrins,  defensin RTD-1, 
and other cases in which the core represents the scaffold around which helices and sheets packs, 
as for kinocidins.[12, 13] 
In a recent paper we identified, after a bioinformatics analysis of the tomato genome, the tomato 
defensin SolyC07g007760 (iTAG v.2.3) and demonstrated that a synthetic peptide (SolyC) 
corresponding to its  core exerts antimicrobial activity against both Gram positive and Gram 
negative bacteria, being particularly active against different strains of the Gram negative 
bacterium H. pylori.[14, 15] Interestingly the peptide SolyC was able to discriminate between 
pathogens and probiotic bacteria, killing only the minority of the probiotic tested. In addition, 
SolyC down-regulated the pro-inflammatory cytokines to an extent comparable to the known anti-
inflammatory drug acetyl salicylic acid , did not cause red blood cell hemolysis and was not toxic 
toward eukaryotic cells. 
SolyC is a peptide composed by 17 amino acids and contains three cysteines in positions 6, 13 and 
15. The results described so far were obtained employing the peptide in its linear form. The 
presence of three cysteines which might be subjected to spontaneous oxidation and the 
observation that in typical  cores those cysteines are involved in disulfide bonds urged us to 
investigate how formation of disulfide bonds in a controlled fashion could affect the secondary 
structure and the antimicrobial activity of the peptide. Two peptides in which Cys13 or Cys15 was 
mutated into a serine were obtained in the linear and oxidized form. Disulfide bonds were formed 
between C6 and C13 (SolyC1) or C6 and C15 (SolyC2); in both cases one cysteine was missing. 
Truncated peptides, starting from the conserved GXC motif were also obtained in the linear and 
oxidized form. The secondary structure of all peptides was analyzed by Circular Dichroism; the 
antimicrobial activity of the peptides was tested against Gram positive and Gram negative 
bacteria. All the oxidized peptides are highly active against Gram negative bacteria; the linear 
peptide SolyC2 shows antimicrobial activity against Gram negative bacteria comparable to that of 
the reference peptide SolyC, while linear SolyC1 exhibits an antimicrobial activity against Gram 
negative bacteria at higher concentrations. The activity of modified peptides against Gram positive 
bacteria was found in all cases lower as compared to that of the reference peptide. These results 
suggest that the interaction of the peptides with the membranes of Gram negative bacteria is 
stronger when the positive charges are exposed and this likely occurs when the peptides are in the 
oxidized form, in which the antiparallel  sheets are constrained by the disulfide bond. 
 
Materials and methods 
Reagents 
The amino acids used for the peptide synthesis, Fmoc-Arg(Pbf)-OH, Fmoc-Asn(Trt)-OH, Fmoc-
Cys(Trt)-OH, Fmoc-Gly-OH, Fmoc-Lys(Boc)-OH, Fmoc-Phe-OH, Fmoc-Ser(OtBu)-OH, Fmoc-Thr(tBu)-
OH , the Rink amide MBHA resin and the activators N-Hydroxybenzotriazole (HOBT) and O-
Benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate (HBTU) were purchased from 
Novabiochem (Gibbstown, NJ, USA). Acetonitrile (ACN) was from Reidel-deHaën (Seelze, Germany) 
and dry N,N-dimethylformamide (DMF) from LabScan (Dublin, Ireland). All other reagents were 
from Sigma Aldrich (Milan, Italy). LC-MS analyses were performed on a LC-MS Thermo Finnigan 
with an electrospray source (MSQ) on a Phenomenex Jupiter 4μ Proteo (50x4.6 mm) column for all 
peptides except for SolyC-t which was analysed on a Jupiter 4μ Proteo (150x4.6 mm) column. 
Purification was carried out on a Onyx monolithic semi-prep C18 (100x10mm) column. 
Synthesis 
Peptides were synthesised on solid phase by Fmoc chemistry on the MBHA (0.54 mmol/g) resin by 
consecutive deprotection, coupling and capping cycles.[16] Deprotection: 30% piperidine in DMF, 
5 minutes (2x). Coupling: 2.5 equivalents of amino acid + 2.49 equivalent of HOBT/HBTU (0.45 M in 
DMF/DMSO 75/25 v/v) + 3.5 equivalents NMM, 40 minutes. Capping: acetic 
anhydride/DIPEA/DMF 15/15/70 v/v/v, 5 minutes. 
Peptides were cleaved off the resin and deprotected by treatment of the resin with a solution of 
TFA/TIS/EDT/H2O 94/1/2.5/2.5 v/v/v/v, 3h, rt. TFA was concentrated and peptides were 
precipitated in cold ethylic ether. Analysis of the crudes was performed by LC-MS using a gradient 
of acetonitrile (0.1% TFA) in water (0.1% TFA) from 5 to 70% in 15 minutes. Purification was 
performed by semipreparative RP-HPLC using a gradient of acetonitrile (0.1% TFA) in water (0.1% 
TFA) from 5 to 70% in 15  minutes.  
 
SolyC (Da): Calculated for 1994.32: [M+2H]2+: 998.16; [M+3H]3+: 665.77; Found:  [M+2H]2+: 997.55; 
[M+3H]3+: 665.64; 
Retention Time: 5.40 min 
SolyC-t (Da): Calculated for 1703.01: [M+2H]2+: 853.50;  [M+3H]3+: 568.67; Found: [M+1H]1+: 
1702.58;  [M+2H]2+: 852.29;  [M+3H]3+: 568.52;  
Retention Time: 12.0 min 
SolyC1 (Da): Calculated for 1978.26: [M+2H]2+: 990.13; [M+3H]3+: 660.42; Found: [M+2H]2+: 
990,13; [M+3H]3+: 660.41; 
Retention Time: 5.12 min 
SolyC1-t (Da) Calculated for  1686.95: [M+2H]2+: 844.47; [M+3H]3+: 563.31; Found: [M+2H]2+: 
844.40; [M+3H]3+: 563.21; 
Retention Time: 5.12 min 
SolyC2 (Da): Calculated for  1978.26 [M+2H]2+: 990.13; [M+3H]3+: 660.42; Found: [M+2H]2+: 
989.90; [M+3H]3+: 660.21 
Retention Time: 5.33 min 
SolyC2-t (Da): Calculated for 1686.95: [M+2H]2+: 844.47; [M+3H] 3+: 563.31; Found: [M+2H]2+: 
844.03; [M+3H]3+: 563.23; 
Retention Time: 4.93 min 
 
Oxidation reaction 
Disulfide-bridged analogues were obtained from the purified linear peptides after an oxidation 
reaction. Linear peptides  were dissolved in a mixture of  H2O/acetic acid (95/5, v/v) at a final 
concentration of 2.5mM (9mL total volume);  pH was adjusted to 6 with ammonium hydrogen 
carbonate and then DMSO (1 mL) was added. The reaction was complete after 24h.   Analysis of 
the crudes was performed by LC-MS using a gradient of acetonitrile (0.1% TFA) in water (0.1% TFA) 
from 5 to 70% in 15 minutes. Purification was performed by semipreparative RP-HPLC using a 
gradient of acetonitrile (0.1% TFA) in water (0.1% TFA) from 5 to 70% in 15  minutes. 
 
SolyC1_ox (Da): Calculated for 1976.26: [M+2H]2+: 989.13; [M+3H]3+: 659.75; Found: [M+2H]2+: 
988.70; [M+3H]3+: 659.60; 
Retention Time: 5.35 min 
SolyC1-t-ox (Da): Calculated for 1684.94: [M+2H]2+: 843.47; [M+3H]3+: 562.64; Found: [M+2H]2+: 
843.23; [M+3H]3+: 562.53; 
Retention Time: 4.96 min 
Solyc2-ox (Da): Calculated for 1976.26: [M+2H]2+: 989.13; [M+3H]3+: 659.75; Found: [M+2H]2+: 
988.60; [M+3H]3+: 659.60; 
Retention Time: 5.10 min 
SolyC2-t-ox (Da): Calculated for 1684.94: [M+2H]2+: 843.47; [M+3H]3+: 562.64; Found: [M+2H]2+: 
843.26; [M+3H]3+: 562.50; 
Retention Time: 5.15 min 
Bacteria 
Bacterial isolates were from patients hospitalized at the Medical School of the University of Naples 
“Federico II” and at the “Villa Betania” hospital (Naples, Italy). Species identification was carried 
out by PCR.[17-21] Bacteria were grown at 37°C in TSB or LB medium, harvested in the exponential 
phase (OD 600 nm 0.6-0.8), centrifuged (10 min at 8x103 g) and resuspended in Muller Hinton 
broth at the concentration of ~105 CFU/ml. The resistance/susceptibility of the different strains 
used in this study to conventional antibiotics were also determined using the disk diffusion 
method on Mueller-Hinton agar according to the NCCLS guidelines 2002 (data not shown) 
 
Antibacterial and haemolytic activity 
Bacteria were distributed in triplicate into plates (60 µl/well), mixed with dilutions of the peptides 
(5 – 100 µg/ml; 40 µl/well) and incubated at 37°C for 20 h. The minimal concentration of peptides 
causing 100% growth inhibition (MIC100), was determined by measuring the absorbance at 600 
nm (Biorad microplate reader model 680, CA).[22] The test was performed in triplicate. The 
haemolytic activity of the peptides was tested using mouse red blood cells.   The haemolytic 
activity was measured according to the formula OD peptide - OD negative control/OD positive 
control - OD negative control x 100 where the negative control (0% haemolysis) was represented 
by erythrocytes suspended in saline and the positive control (100% haemolysis) was represented 
by the erythrocytes lysed with 1% triton X100 .[22] 
The LC50 value relative to the SolyC was calculated as described.[23]   
 Circular dichroism 
Circular dichroism (CD) spectra were recorded at 25° C using a 1 cm quartz cell with the Jasco-810 
spectropolarimeter using a 260 – 200 nm measurement range, 100 nm/min scanning speed, 1nm 
bandwidth, 4 sec response time, 0.5 nm data pitch. 
Peptides concentration for CD measurement was 25 μM. CD spectra were registered in 10 mM 
sodium phosphate buffer, pH 7 and in 10 mM  sodium phosphate,  20 mM SDS buffer, pH 7.  
 
 Results  
Peptide design and synthesis 
The SolyC peptide (Table 1) contains the core sequence of the tomato defensin Solyc07g007760 
and shows strong similarity in the primary sequence with the levomeric form of porcine protegrin 
PG-1. In PG-1 four cysteines form two disulfide bonds, one involving C6 and C15 and the other C8 
and C13, which force the peptide to fold into two antiparallel beta sheets; the oxidation of 
cysteines induces the formation of a turn characterized by a strong concentration of positive 
charges.[24, 25] 
SolyC contains only three cysteines, therefore, in order to induce the peptide to assume a PG-1 
like structure, only one disulfide bond can be formed. We designed two peptides with a different 
disulfide pattern, with the aim to explore the effect of cyclization on the antimicrobial activity of 
the peptide, to understand whether there is a preference for the formation of one of the two 
disulfides and also whether there is a difference in the activity of the peptides with cycles of 
different size (Table 1). Since in  cores cysteines contained in sequences CXC are rarely connected 
by disulfide bonds[26], we explored only two of the possible combinations of disulfides, namely 
C6-C13 (SolyC1) and C6-C15 (SolyC2) and mutated the cysteine not involved in the disulfide into a 
serine. In order to investigate the effect of reducing the hydrophobicity of the peptide, we also 
obtained truncated peptides, lacking three amino acids at the N-terminus. In the truncated  
peptides the residues which characterize the  core motif GXC were conserved (Table 1). HPLC 
retention times for truncated peptides are similar or lower as compared to those of the full length 
peptides, as expected comparing the mean hydrophobicity calculated for each peptide (Table 
1).[27] 
All peptides were obtained in the linear and oxidized form. Oxidation was carried out incubating 
linear peptides with DMSO (10%) at pH 6.0. LC-MS analysis of the peptides, showing for the 
majority of the peptides a decrease of the retention time and a reduction of 2 units in the mass, 
confirmed that the reaction occurred (Figure 2). 
Secondary structure studies 
Linear and oxidized peptides were analyzed by Circular Dichroism at a 50M concentration in 
Phosphate buffer, pH7. Peptides are mostly in an unordered form; spectra for the linear peptides, 
in fact, show one minimum around 204 nm and a very shallow minimum around 230 nm; upon 
oxidation the minimum shifts toward 207 nm. Spectra recorded in the presence of SDS 30 mM are 
in most cases very similar to those recorded in buffer, but more intense (Figure 3).  
Antimicrobial activity test 
The antimicrobial activity of the peptides was tested against the Gram positive bacteria S. aureus, 
S. epidermidis, L. monocytogenes and against the Gram negative bacteria H.pylori and S. enterica. 
(Table 2) For the standard peptide SolyC, truncation results in loss of activity against the Gram 
positive Staphilococci, while no difference was found when the peptides SolyC and SolyC-t were 
tested against Gram negative bacteria. When tested against Gram positive bacteria, the analogues 
containing two cysteines (SolyC1 and SolyC2) show a reduced antimicrobial ability as compared to 
the reference peptide SolyC; MIC values are in all cases higher than that of SolyC and there is no 
large difference between the activity of linear and oxidized peptides. Peptides are in general more 
active against Gram negative bacteria; linear peptides show lower MIC in the full length version as 
compared to the truncated form. Noteworthy SolyC2, the peptide having the disulfide between C6 
and C15, shows activity identical to that of the reference peptide. Oxidation results in an increase 
of the antimicrobial activity of the modified peptides against Gram negative bacteria, either in the 
extended or in the truncated form: all oxidized peptides exhibit activity identical or comparable to 
that of the reference peptide. 
The hemolytic activity of the peptides was tested for all peptides at several concentrations (Figure 
4). Up to 90g/mL all peptides have hemolytic activity below 30%. At low concentrations all long 
linear peptides and the oxidized form of SolyC1 show hemolytic activity comparable to that of 
truncated peptides. Interestingly SolyC2 has in the long oxidized form (SolyC2-ox) very low 
hemolytic activity, comparable to that of the standard peptide. 
LC50 measured for all peptides was found lower for the peptides containing only two cysteines as 
compared to SolyC (Table 3). The lowest LC50 value was observed for SolyC2 in the oxidized form 
(SolyC2-ox). 
 
Discussion 
Peptides containing a  core motif and in particular analogues of protegrins have widely been 
studied as they are capable to exert antimicrobial activity even at high salt concentrations, unlike 
other antimicrobial peptides which form sheets such as  defensins.[28, 29] Interestingly, the PG-1 
analogue IB-367 has been tested in phase II clinical trials for the treatment of oral mucositis and 
PG-1 based peptidomimetics were found to be active at nanomolar concentrations against 
Pseudomonas aeruginosa.[30, 31] It has been reported that the stabilization of the hairpin is 
necessary for the activity: PG-1 analogues lacking cysteines, in which the hairpin is stabilized by a 
tryptophan zipper motif, possess antimicrobial activity comparable to PG-1.[32] In PG-1 the 
number of disulfide bonds and their position affect the activity; analogues of PG-1 with a single 
disulfide bond possess antimicrobial activity comparable to PG-1 in the linear form. 
The  core of the tomato defensin family, to which SolyC peptides belong, has a strong similarity in 
the amino acid sequence with the core of other plant defensins as the Medicago sativa defensin 
4 (MtDef4), and also with the levomeric form of PG-1.[9, 33] The three-dimensional structures of 
plant defensins, which are composed of about 50-60 amino acids, are very complex and cysteines 
belonging to the  core form disulfide bonds with cysteines located outside of the  core.[34-36] In 
self-consistent  cores as PG-1 and RTD-1, instead, the beta-hairpin structure is stabilized by two 
disulfide bonds between cysteines inside the  core. SolyC is a fragment of a tomato defensin and, 
as most of the plant defensins, has a very conserved GXCRG motif within the  core with three 
cysteins. It is reasonable to think that SolyC has a structural organization similar to that of plant 
defensin in which cysteines in the  core are not connected between them. As we have 
demonstrated in a previous paper that the linear fragment SolyC possess high antimicrobial 
activity, we now explored the possibility of stabilizing the peptide structure introducing in a 
controlled fashion one disulfide bond, and evaluated the effects of cyclization on the peptide 
antimicrobial activity and secondary structure. Furthermore similar studies were carried out on 
truncated peptides. 
In SolyC cysteins are located in position i, i+7 and i+9; peptides with disulfide bonds between Cys i 
–i+7 (SolyC1) and i-i+9 (SolyC2) were obtained.  The secondary structure of all peptides was 
analyzed by CD in phosphate buffer and in phosphate buffer containing SDS: both linear and 
oxidized peptides seems to be in an unordered form (Figure 3). All the analogues are more active 
against Gram negative than against Gram positive bacteria; these results are in line to what 
reported for PG-1 and PG-1 analogues with a single disulfide bond.[28] Interestingly, cyclic 
peptides are generally more active than linear ones against Gram negative bacteria. Cyclization 
induce a strong polarization of the peptides, confining the positive charge in the turn and the 
hydrophobic residues on the “tails”, and reasonably allows the peptide to interact with the 
bacterial LPS, neutralizing and permeating it. (Figure 5) Recent studies aimed to characterize the 
interaction of rationally designed peptides with the LPS demonstrate that amphipatic peptides are 
active antimicrobials as they assume the structure of a boomerang upon interaction with LPS, 
exerting their activity by disgregating it.[37] These peptides are mimics of the outer membrane, as 
they possess a polar head and hydrophobic tails and easily intercalate into LPS. The SolyC cyclic 
analogues are already in the active conformation with the segregation of charges and therefore it 
is likely that they exert their activity as the  boomerang peptides do. 
SolyC2 in the full length and truncated version shows antimicrobial activity identical to that of the 
reference peptide SolyC. These result may be interpreted hypothesizing that, in the experimental 
conditions employed for the activity test, SolyC spontaneously oxidizes and the formation of the 
disulfide bond between Cys in position i and i+9 is favored. As in SolyC2 only the disulfide bridge 
between Cys i and i+9 can be formed, it is reasonable to think that the linear peptide 
spontaneously converts into the oxidized form which corresponds also to the active form. This 
hypothesis is consistent with the observation that full length SolyC2 in the linear and oxidized form 
has the same antimicrobial activity as the reference SolyC. Interestingly in SolyC2 the cysteines 
involved in the disulfide bond are located in positions identical to external cysteines of PG-1, 
reproducing the cyclization pattern of the highly active “bullet” peptide proposed by Harwig.[28] 
The observation that there is no difference in the activity against Gram negative bacteria of cyclic 
SolyC1 and SolyC2 derivatives, which differ in the number of amino acids included in the cycle, 
suggests that the charge segregation and not the dimension of the cycle is crucial for activity. 
All peptides at concentrations up to threefold that of MIC show very low hemolytic activity, 
indicating that these peptides are selective for bacterial outer membrane. The lowest percentage 
of hemolytic activity was found for the oxidized SolyC2. LC50 calculated for all peptides on murine 
red blood cells is lower for SolyC2, confirming the selectivity for negatively charged membrane (as 
the bacterial LPS) versus  zwitterioninc membranes (as the erythrocytes). 
In conclusion, we have demonstrated that isolated  cores of plant defensins possess strong 
antimicrobial activity against Gram negative bacteria; formation of an intramolecular disulfide 
bond stabilizes the peptides in the “active” conformation. We found that the peptide SolyC2, 
which reproduces the disulfide bond pattern observed in PG-1, shows an high selectivity towards 
bacterial outer membrane, showing very low hemolytic activity at concentrations which are 
threefold the MIC.  These results encourage future studies on the antimicrobial activity of isolated 
 cores peptides from plants, due to their strength and specificity of action. 
 
 
Reference 
[1] T. Ganz, Defensins: antimicrobial peptides of innate immunity, Nat Rev Immunol, 3 (2003) 710-720. 
[2] M. Zanetti, R. Gennaro, D. Romeo, Cathelicidins: a novel protein family with a common proregion and a 
variable C-terminal antimicrobial domain, FEBS Lett, 374 (1995) 1-5. 
[3] B. Schittek, R. Hipfel, B. Sauer, J. Bauer, H. Kalbacher, S. Stevanovic, M. Schirle, K. Schroeder, N. Blin, F. 
Meier, G. Rassner, C. Garbe, Dermcidin: a novel human antibiotic peptide secreted by sweat glands, Nat 
Immunol, 2 (2001) 1133-1137. 
[4] M.S. Castro, W. Fontes, Plant defense and antimicrobial peptides, Protein Pept Lett, 12 (2005) 13-18. 
[5] B. Stec, Plant thionins--the structural perspective, Cell Mol Life Sci, 63 (2006) 1370-1385. 
[6] L. Chiche, A. Heitz, J.C. Gelly, J. Gracy, P.T. Chau, P.T. Ha, J.F. Hernandez, D. Le-Nguyen, Squash 
inhibitors: from structural motifs to macrocyclic knottins, Curr Protein Pept Sci, 5 (2004) 341-349. 
[7] M.R. Yeaman, N.Y. Yount, Unifying themes in host defence effector polypeptides, Nat Rev Microbiol, 5 
(2007) 727-740. 
[8] N.Y. Yount, M.T. Andres, J.F. Fierro, M.R. Yeaman, The gamma-core motif correlates with antimicrobial 
activity in cysteine-containing kaliocin-1 originating from transferrins, Biochim Biophys Acta, 1768 (2007) 
2862-2872. 
[9] N.Y. Yount, M.R. Yeaman, Multidimensional signatures in antimicrobial peptides, Proc Natl Acad Sci U S 
A, 101 (2004) 7363-7368. 
[10] M.R. Yeaman, N.Y. Yount, A.J. Waring, K.D. Gank, D. Kupferwasser, R. Wiese, A.S. Bayer, W.H. Welch, 
Modular determinants of antimicrobial activity in platelet factor-4 family kinocidins, Biochim Biophys Acta, 
1768 (2007) 609-619. 
[11] P.B. Pelegrini, O.L. Franco, Plant gamma-thionins: novel insights on the mechanism of action of a multi-
functional class of defense proteins, Int J Biochem Cell Biol, 37 (2005) 2239-2253. 
[12] D.A. Steinberg, M.A. Hurst, C.A. Fujii, A.H. Kung, J.F. Ho, F.C. Cheng, D.J. Loury, J.C. Fiddes, Protegrin-1: 
a broad-spectrum, rapidly microbicidal peptide with in vivo activity, Antimicrob Agents Chemother, 41 
(1997) 1738-1742. 
[13] D. Tran, P.A. Tran, Y.Q. Tang, J. Yuan, T. Cole, M.E. Selsted, Homodimeric theta-defensins from rhesus 
macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the 
cyclic peptides, J Biol Chem, 277 (2002) 3079-3084. 
[14] The tomato genome sequence provides insights into fleshy fruit evolution, Nature, 485 (2012) 635-641. 
[15] M.M. Rigano, A. Romanelli, A. Fulgione, N. Nocerino, N. D'Agostino, C. Avitabile, L. Frusciante, A. 
Barone, F. Capuano, R. Capparelli, A novel synthetic peptide from a tomato defensin exhibits antibacterial 
activities against Helicobacter pylori, J Pept Sci, (2012) doi: 10.1002/psc.2462. 
[16] A. Romanelli, L. Moggio, R.C. Montella, P. Campiglia, M. Iannaccone, F. Capuano, C. Pedone, R. 
Capparelli, Peptides from Royal Jelly: studies on the antimicrobial activity of jelleins, jelleins analogs and 
synergy with temporins, J Pept Sci, 17 (2011) 348-352. 
[17] K. Becker, R. Roth, G. Peters, Rapid and specific detection of toxigenic Staphylococcus aureus: use of 
two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin 
genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene, J Clin Microbiol, 36 (1998) 2548-
2553. 
[18] Y. Hong, T. Liu, M.D. Lee, C.L. Hofacre, M. Maier, D.G. White, S. Ayers, L. Wang, R. Berghaus, J.J. 
Maurer, Rapid screening of Salmonella enterica serovars Enteritidis, Hadar, Heidelberg and Typhimurium 
using a serologically-correlative allelotyping PCR targeting the O and H antigen alleles, BMC Microbiol, 8 
(2008) 178. 
[19] M.L. Tomasini, S. Zanussi, M. Sozzi, R. Tedeschi, G. Basaglia, P. De Paoli, Heterogeneity of cag 
genotypes in Helicobacter pylori isolates from human biopsy specimens, J Clin Microbiol, 41 (2003) 976-
980. 
[20] A. Bubert, I. Hein, M. Rauch, A. Lehner, B. Yoon, W. Goebel, M. Wagner, Detection and differentiation 
of Listeria spp. by a single reaction based on multiplex PCR, Appl Environ Microbiol, 65 (1999) 4688-4692. 
[21] F. Martineau, F.J. Picard, P.H. Roy, M. Ouellette, M.G. Bergeron, Species-specific and ubiquitous DNA-
based assays for rapid identification of Staphylococcus epidermidis, J Clin Microbiol, 34 (1996) 2888-2893. 
[22] R. Capparelli, A. Romanelli, M. Iannaccone, N. Nocerino, R. Ripa, S. Pensato, C. Pedone, D. Iannelli, 
Synergistic antibacterial and anti-inflammatory activity of temporin A and modified temporin B in vivo, PLoS 
One, 4 (2009) e7191. 
[23] J. Vinhal Costa Orsine, R. Vinhal da Costa, R. Carvalho da Silva, M. de Fatima Menezes Almeida Santos, 
M.R. Carvalho Garbi Novaes, The acute cytotoxicity and lethal concentration (LC50) of Agaricus sylvaticus 
through hemolytic activity on human erythrocyte, International Journal of Nutrition and Metabolism, 4 
(2012) 19-23. 
[24] R.L. Fahrner, T. Dieckmann, S.S. Harwig, R.I. Lehrer, D. Eisenberg, J. Feigon, Solution structure of 
protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes, Chem Biol, 3 (1996) 543-550. 
[25] R. Mani, S.D. Cady, M. Tang, A.J. Waring, R.I. Lehrer, M. Hong, Membrane-dependent oligomeric 
structure and pore formation of a beta-hairpin antimicrobial peptide in lipid bilayers from solid-state NMR, 
Proc Natl Acad Sci U S A, 103 (2006) 16242-16247. 
[26] N.Y. Yount, M.R. Yeaman, Emerging themes and therapeutic prospects for anti-infective peptides, 
Annu Rev Pharmacol Toxicol, 52 (2012) 337-360. 
[27] J. Kyte, R.F. Doolittle, A simple method for displaying the hydropathic character of a protein, J Mol Biol, 
157 (1982) 105-132. 
[28] S.S. Harwig, A. Waring, H.J. Yang, Y. Cho, L. Tan, R.I. Lehrer, Intramolecular disulfide bonds enhance the 
antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations, Eur J 
Biochem, 240 (1996) 352-357. 
[29] M.J. Goldman, G.M. Anderson, E.D. Stolzenberg, U.P. Kari, M. Zasloff, J.M. Wilson, Human beta-
defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis, Cell, 88 (1997) 553-560. 
[30] D.A. Mosca, M.A. Hurst, W. So, B.S. Viajar, C.A. Fujii, T.J. Falla, IB-367, a protegrin peptide with in vitro 
and in vivo activities against the microflora associated with oral mucositis, Antimicrob Agents Chemother, 
44 (2000) 1803-1808. 
[31] N. Srinivas, P. Jetter, B.J. Ueberbacher, M. Werneburg, K. Zerbe, J. Steinmann, B. Van der Meijden, F. 
Bernardini, A. Lederer, R.L. Dias, P.E. Misson, H. Henze, J. Zumbrunn, F.O. Gombert, D. Obrecht, P. Hunziker, 
S. Schauer, U. Ziegler, A. Kach, L. Eberl, K. Riedel, S.J. DeMarco, J.A. Robinson, Peptidomimetic antibiotics 
target outer-membrane biogenesis in Pseudomonas aeruginosa, Science, 327 (2010) 1010-1013. 
[32] J.R. Lai, B.R. Huck, B. Weisblum, S.H. Gellman, Design of non-cysteine-containing antimicrobial beta-
hairpins: structure-activity relationship studies with linear protegrin-1 analogues, Biochemistry, 41 (2002) 
12835-12842. 
[33] U.S. Sagaram, R. Pandurangi, J. Kaur, T.J. Smith, D.M. Shah, Structure-activity determinants in 
antifungal plant defensins MsDef1 and MtDef4 with different modes of action against Fusarium 
graminearum, PLoS One, 6 (2011) e18550. 
[34] B.J. Janssen, H.J. Schirra, F.T. Lay, M.A. Anderson, D.J. Craik, Structure of Petunia hybrida defensin 1, a 
novel plant defensin with five disulfide bonds, Biochemistry, 42 (2003) 8214-8222. 
[35] F. Fant, W. Vranken, W. Broekaert, F. Borremans, Determination of the three-dimensional solution 
structure of Raphanus sativus antifungal protein 1 by 1H NMR, J Mol Biol, 279 (1998) 257-270. 
[36] F. Fant, W.F. Vranken, F.A. Borremans, The three-dimensional solution structure of Aesculus 
hippocastanum antimicrobial protein 1 determined by 1H nuclear magnetic resonance, Proteins, 37 (1999) 
388-403. 
[37] A. Bhunia, H. Mohanram, P.N. Domadia, J. Torres, S. Bhattacharjya, Designed beta-boomerang 
antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide, J Biol Chem, 284 
(2009) 21991-22004. 
 
 
  
Figure  
Figure 1: Schematic representation of the gamma core isoforms. 
 
Figure 2: Comparison of the LC profiles for SolyC2 in the linear (A) and oxidized form (B). Zoom 
between 4 and 6 minutes of the LC run. 
 
 
Figure 3: CD spectra of SolyC2 (Blue) and SolyC2-ox (red)  (50M) recorded in 10mM Phosphate 
buffer pH7 (continuous line) and in 10mM Phosphate buffer, 30mM SDS pH7 (dotted lines). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Hemolytic activity of the peptides measured at different concentrations. 
 
Figure 5:  Schematic representation of the peptide SolyC2-ox; in red the positively charged amino 
acids in the turn, in yellow the cysteines involved in the disulfide bond and in green the cysteine 
residue mutated into serine. 
 
  
Table1: Peptide sequences, names, reference number and mean hydrophobicity 
Peptide sequence Name Number Mean 
Hydrophobicity 
FSGGNCRGFRRRCFCTK SolyC 1 -0.71 
GNCRGFRRRCFCTK SolyC -t 2 -0.98 
FSGGNCRGFRRRCFSTK SolyC1 3 -0.91 
GNCRGFRRRCFSTK SolyC1-t 4 -1.22 
FSGGNCRGFRRRSFCTK SolyC2 5 -0.91 
GNCRGFRRRSFCTK SolyC2-t 6 -1.22 
 
FSGGNCRGFRRRCFSTK 
SolyC1-ox 
7 --0.91 
 
GNCRGFRRRCFSTK 
SolyC1-t-ox 
8 -1.22 
 
FSGGNCRGFRRRSFCTK 
SolyC2-ox 
9 -0.91 
 
GNCRGFRRRSFCTK 
SolyC2-t-ox 
10 -1.22 
 
  
Table2: Antimicrobial activity of the peptides against Gram positive and Gram negative bacteria 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
STRAINS MIC100 (g/ml) 
 Peptide number 
 1 2 3 4 5 6 7 8 9 10 
Staphylococcus aureus 40  50  50  50  80  80  80  50  100  80  
Staphylococcus epidermidis 40  80  100  100  100  100  100  100  100  100  
Listeria monocytogenes 80  80  80  80  80  80  80  80  80  80  
Salmonella serovar paratyphi B 15  15  40  80  15  40  15  15  15  20  
Helicobacter pylori 15  15  15  15  15  20  15  15  20  20  
  
 
Table3: LC50 for the SolyC and SolyC analogues 
 Peptide number 
 1 2 3 4 5 6 7 8 9 10 
LC 50 (µg/ml) 275.2 266.7 212.3 228.5 226.5 213.0 229.6 231.0 197.4 235.1 
 
